Courage Capital Management LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Courage Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.63 - $0.96 $420,937 - $641,427	-668,154 Reduced 66.82%	331,846 $262,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $450,000 - $954,000	-900,000 Reduced 47.37%	1,000,000 $804,000
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.22 $184,000 - $244,000	200,000 Added 11.76%	1,900,000 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $134,000 - $302,000	200,000 Added 13.33%	1,700,000 $2.21 Million
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.1 $1.13 Million - $1.65 Million	1,500,000 New	1,500,000 $1.16 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $115M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.